Retrospective Study
Copyright ©The Author(s) 2023.
World J Med Genet. Dec 20, 2023; 11(4): 39-50
Published online Dec 20, 2023. doi: 10.5496/wjmg.v11.i4.39
Table 1 Demographics of 100 patients included in the retrospective review of pharmacogenomics result
Patient characteristics
Sex(%)
Male44
Female56
Age (yr)(%)
18-2923
30-3912
40-4929
50-5917
60-6914
> 705
Referring specialists(%)
Psychiatrists39
Immunologists15
General practitioners10
Neurologists9
Transplant physicians8
Clinical pharmacologists5
Others114
Indications for referral(%)
To guide pharmacotherapy62
Previous drug reactions51
Polypharmacy25
Pre-emptive testing5
Did not specify5
Table 2 Number of patients (n = 56) taking medications found to have high- and/or moderate-risk drug-gene interaction against the number of such medications, in those whose medication history was available (n = 84), n (%)
Number of medications with implicated DGI
Number of patients taking medications with high-risk +/- moderate-risk DGI implicated
Number of patients taking medications with moderate-risk DGI implicated only
Number of patients taking medications with an actionable1 DGI
15 (6)20 (24)25 (30)
27 (8)11 (13)18 (21)
33 (4)7 (8)10 (12)
41 (1)0 (0)1 (1)
50 (0)1 (1)1 (1)
60 (0)0 (0)0 (0)
70 (0)0 (0)0 (0)
80 (0)0 (0)0 (0)
91 (1)0 (0)1 (1)
100 (0)0 (0)0 (0)
Total17 (20)39 (46)56 (66)
Table 3 Patient and clinician survey respondent demographics, n (%)
Patient respondents (n = 25)

Clinician respondents (n = 17)

SexSex
Male9 (36.0)Male11 (64.7)
Female16 (64.0)Female6 (35.3)
Patient age (yr)Clinician attained medical degree
18-294 (16.0)Before 19802 (11.8)
30-392 (8.0)1981-19902 (11.8)
40-497 (28.0)1991-20003 (17.6)
50-596 (24.0)After 200010 (58.8)
60-695 (20.0)
> 701 (4.0)
Patient education levelClinician specialty
Did not finish high school1 (4.0)Psychiatry5 (29.4)
High school6 (24.0)Clinical pharmacology3 (17.6)
Certificate or diploma5 (20.0)Immunology2 (11.8)
Bachelor’s degree11 (44.0)Neurology2 (11.8)
Master’s degree or doctorate2 (8.0)General practitioner1 (5.9)
Other17 (41.2)